DrugSep 23, 2020
RLC Labs WP Thyroid, Westhroid Pure, 1 Grain (65 mg) Thyroid USP recall — FDA D-1609-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
Recall history in this database
Classification mix: Class II: 18, Class I: 6.
DrugSep 23, 2020
RLC Labs Nature-Throid, Thyroid USP [liothyronine (T3) 15.75 mcg and levothyroxine (T4) 66.5 recall — FDA D-1601-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature-Throid, Thyroid USP [liothyronine (T3) 11.25 mcg and levothyroxine (T4) 47.5 recall — FDA D-1599-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature-Throid, Thyroid USP [liothyronine (T3) 6.75 mcg and levothyroxine (T4) 28.5 recall — FDA D-1597-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature-Throid, Thyroid USP [liothyronine (T3) 4.5 mcg and levothyroxine (T4) 19 recall — FDA D-1598-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature-Throid, Thyroid USP [liothyronine (T3) 22.5 mcg and levothyroxine (T4) 95 recall — FDA D-1604-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature Throid, 1.25 Grain (81.25 mg) Thyroid USP [Liothyronine (T3) 11.25 mcg recall — FDA D-1617-2020
Subpotent Drug: FDA analysis found product to be subpotent
Class IFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature-Throid, Thyroid USP [liothyronine (T3) 20.25 mcg and levothyroxine (T4) 85.5 recall — FDA D-1603-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs WP Thyroid, Westhroid Pure, 3/4 Grain (48.75 mg) Thyroid USP recall — FDA D-1608-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs WP Thyroid, Westhroid Pure, 2 Grain (130 mg) Thyroid USP recall — FDA D-1613-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature Throid, 1.5 Grain (97.5 mg) Thyroid USP [Liothyronine (T3) 13.5 mcg recall — FDA D-1619-2020
Subpotent Drug: FDA analysis found product to be subpotent
Class IFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs WP Thyroid, Westhroid Pure, 1.25 Grain (81.25 mg) Thyroid USP recall — FDA D-1610-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature-Throid, Thyroid USP [liothyronine (T3) 9 mcg and levothyroxine (T4) 38 mcg] recall — FDA D-1596-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 recall — FDA D-1614-2020
Subpotent Drug: FDA analysis found product to be subpotent
Class IFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature-Throid, Thyroid USP [liothyronine (T3) 13.5 mcg and levothyroxine (T4) 57 recall — FDA D-1600-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs WP Thyroid, Westhroid Pure, Thyroid USP, [liothyronine (T3) 2.25 mcg and recall — FDA D-1606-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature-Throid, Thyroid USP [liothyronine (T3) 27 mcg and levothyroxine (T4) 114 recall — FDA D-1605-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP recall — FDA D-1607-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs WP Thyroid, Westhroid Pure, 1.75 Grain (113.75 mg) Thyroid USP recall — FDA D-1612-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature Throid, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg recall — FDA D-1615-2020
Subpotent Drug: FDA analysis found product to be subpotent
Class IFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature-Throid, Thyroid USP [liothyronine (T3) 18 mcg and levothyroxine (T4) 76 recall — FDA D-1602-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs WP Thyroid, Westhroid Pure, 1.5 Grain (97.5 mg) Thyroid USP recall — FDA D-1611-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class IIFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature Throid, 2 Grain (130 mg) Thyroid USP [Liothyronine (T3) 18 mcg recall — FDA D-1618-2020
Subpotent Drug: FDA analysis found product to be subpotent
Class IFDA: TerminatedRLC Labs Inc.
DrugSep 23, 2020
RLC Labs Nature Throid, 3/4 Grain (48.75 mg) Thyroid USP [Liothyronine (T3) 6.75 mcg recall — FDA D-1616-2020
Subpotent Drug: FDA analysis found product to be subpotent
Class IFDA: TerminatedRLC Labs Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies RLC Labs Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.